Emma Beausang active positions
| Companies | Position | Start | End |
|---|---|---|---|
| GH RESEARCH PLC | General Counsel | - | - |
Career history of Emma Beausang
Former positions of Emma Beausang
| Companies | Position | Start | End |
|---|---|---|---|
| AERIE PHARMACEUTICALS, INC. | General Counsel | - | 30/11/2021 |
Training of Emma Beausang
| University of Strathclyde | Undergraduate Degree |
| UCL School of Pharmacy | Doctorate Degree |
Statistics
International
| United Kingdom | 3 |
| United States | 2 |
| Ireland | 2 |
Operational
| General Counsel | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| GH RESEARCH PLC | Health Technology |
| Private companies | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Stock Market
- Insiders
- Emma Beausang
- Experience
